12 articles tagged with #medical-research. AI-curated summaries with sentiment analysis and key takeaways from 50+ sources.
AIBullisharXiv – CS AI · Mar 277/10
🧠Researchers developed AD-CARE, an AI agent that uses large language models to diagnose Alzheimer's disease from incomplete medical data across multiple modalities. The system achieved 84.9% diagnostic accuracy across 10,303 cases and improved physician decision-making speed and accuracy in clinical studies.
AIBullisharXiv – CS AI · Mar 46/103
🧠Researchers introduce PRISM, an EEG foundation model that demonstrates how diverse pretraining data leads to better clinical performance than narrow-source datasets. The study shows that geographically diverse EEG data outperforms larger but homogeneous datasets in medical diagnosis tasks, particularly achieving 12.3% better accuracy in distinguishing epilepsy from similar conditions.
$COMP
AIBullishOpenAI News · Aug 227/106
🧠OpenAI and Retro Bio collaborated using a specialized AI model called GPT-4b micro to engineer more effective proteins for stem cell therapy and longevity research. This represents a significant application of AI technology in advancing life sciences and medical research capabilities.
AIBullisharXiv – CS AI · Mar 36/108
🧠Researchers have developed MED-COPILOT, an AI-powered clinical decision-support system that combines GraphRAG retrieval with similar patient case analysis to assist healthcare professionals. The system uses structured knowledge graphs from WHO and NICE guidelines along with a 36,000-case patient database to outperform standard AI models in clinical reasoning accuracy.
AINeutralarXiv – CS AI · Mar 37/106
🧠Researchers developed a machine learning approach combining Virtual Twins method with survLIME to identify patient subgroups who respond differently to treatments in clinical trials. The method achieved 0.77 AUC for identifying treatment responders in colorectal cancer trials, finding genetic mutations, metastasis sites, and ethnicity as key response factors.
$CRV
AIBullishOpenAI News · Aug 75/106
🧠The article discusses the application of GPT-5 in medical research, though limited details are provided about specific use cases or implementations. This represents the continued expansion of advanced AI models into healthcare and scientific research applications.
AINeutralarXiv – CS AI · Feb 274/105
🧠Researchers developed a machine learning framework to predict which clinical trials are likely to have high dosing error rates before the trials begin. The system analyzed 42,112 clinical trials and achieved 86.2% accuracy using a combination of structured data and text analysis, enabling proactive risk management in clinical research.
AIBullishMIT News – AI · Feb 254/105
🧠Researchers have developed an AI-driven method that provides holistic information about cells to help scientists better understand disease mechanisms. This approach aims to give researchers a more comprehensive view of cellular processes to improve experimental planning in cell biology.
AIBullishMIT News – AI · Dec 154/104
🧠Researchers have developed a deep-learning model that can predict fruit fly development at the cellular level. The approach has potential applications for analyzing more complex tissues and organs, which could help identify early disease markers.
AINeutralGoogle Research Blog · Aug 64/107
🧠DeepPolisher represents a new AI-driven approach to genome polishing that significantly improves the accuracy of genomic sequencing data. This advancement could enhance the quality and reliability of genomic research foundations across various scientific and medical applications.
AIBullishOpenAI News · Mar 64/105
🧠Paradigm, a healthcare company, is leveraging OpenAI's API to enhance patient access to clinical trials. This application demonstrates the practical use of AI technology in healthcare to address patient recruitment and trial participation challenges.
AINeutralarXiv – CS AI · Mar 34/105
🧠Researchers developed a knowledge graph framework that integrates diverse data sources to predict adverse drug reactions for protein kinase inhibitors. The system combines drug-target data, clinical literature, trial metadata, and safety reports into a unified network for better drug safety analysis and pharmacovigilance.
